Список литературы

1. Бадалян Л.О., Журба Л.Т., Всеволожская Н.М. Руководство по неврологии раннего детского возраста. - Киев: Здоров’я, 1980. - 528 с.

2. Гусев А.С., Гусев С.А., Крылов В.В. Генетика внутричерепных аневризм.

3. Евтушенко С.К., Евтушенко И.С. Мигрень и лакунарные инсульты как базисное проявление церебральной аутосомно-доминантной артериопатии с субкортикальными инфарктами и лейкоэнцефалопатией (CADASIL - синдром) МНЖ. 2011. №8(46). С. 40-42.

4. Евтушенко С.К., Шестова Е.П., Москаленко М.А. Случай CADASIL-синдром у мальчика. Неординарные (раритетные) синдромы заболевания нервной системы у детей и взрослых. —Донецк-Святогорек, 2003. - С. 100-102.

5. Зербино Д.Д., Кузык Ю.И. Патологические деформации сонных артерий. Журналневрологии и психиатрии, 2015-1, 118-123

6. Злотник Э.И., Кузнецов В.Ф., Кастрицкая З.М., Беззубик С.Д. Болезнь «мойя-мойя». Bonp. нейрохир. 1978. № 2. С. 41-46.

7. Иллариошкин C.H., Абрамычева Н.Ю., Калашникова Л.А., Максимова М.Ю., Коновалов Р.Н., Степанова М.С., Федотова Е Ю. Клинический и молекулярно­генетический анализ церебральной аутосомно-доминантной артериопатии с субкортикальными инфарктами и лейкоэнцефалопатией (CADASIL) в российских семьях. Неврологический журнал, № 4, 2013 8.

8. Исакова О.И., Елыкомов В.А., Филатов И.А., Федюнина Н.Г., Козлова Е.А.,

Шульц Т.Э., Иткин Г.П. Инструментальные средства транскраниальной доплерографии в исследовании патогенеза нарушений мозгового кровообращения у детей с патологической извитостью внутренних сонных артерий "Вестник трансплантологии и искусственных органов" № 6(44)'08. - Тверь: Издательство "Триада", 2008. ISSN 1995-1191. с. 53-60

9. Крылов В.В., Годков И.М. Эпидемиология и этиопатогенез аневризм и субарахноидальных кровоизлияний. В книге Хирургия аневризм головного мозга. Под ред. В.В. Крылова.

10. Купч А.Я., Дагиле И.А. Двусторонний экстраинтракраниальный анастомоз при болезни мойя-мойя. Bonp. нейрохир. 1985. № 2. С. 50-51.

11. Лисовская Р.А., Кесаев С.А. Ангиографическое исследование при заболевании «мойя-мойя» Вести, рентгенол. 1980. № 2. С. 38-72.

12. Макаров Н.С., Муравлева Э.А., Спиридонова С.В, Дружинина О.А., Зуев В.В.

Церебральная аутосомно-доминантная артериопатия с субкортикальными инфарктами и лейкоэнцефалопатией (CADASIL): обзор литературы.

Неврологический журнал, 2014 № 6.

13. Медведев Ю.А., Мацко Д.Е. Аневризмы и пороки развития сосудов мозга. СПб.: Изд. РНХЦ им. проф. А.Л. Поленова, 1993. Т. 1. С. 74-76.

14. Мозолевский Ю.В., Янакаева Т.А., Мельникова Е.А. и соавт. Церебральная аутосомно доминантная артериопатия с субкортикальными инфарктами и лейкоэнцефалопатией Неврологический журнал. 2005. № 2. С. 34-40.

15. Москаленко М.А., Евтушенко С.К., Шестова Е.П., Перепечаенко Ю.М., Прохорова Л.М. Особенности диагностики CADASIL синдрома у детей. Международный неврологический журнал 4(4) 2005

16. Панунцев В.C., Христофорова М.И. Болезнь и синдром мойя-мойя. Российский научно-исследовательский нейрохирургический институт им. проф. А.Л. Поленова, Санкт-Петербург. 2003.

17. Пилипенко Ю.В. Аневризмы головного мозга у детей. Автореферат диссертации на соискание ученой степени кандидата медицинских наук. Москва, 2011.

18. Пономарев В.В. Редкие неврологические синдромы и болезни. СПб., 2005. 216 с.

19. Abdul Wahab A, Janahi IA, Eltohami A, et al. A new type of Ehlers-Danlos syndrome associated with tortuous systemic arteries in a large kindred from Qatar. Acta Paediatr. 2003 Apr;92(4):456-62.

20. Adib-Samii P., Brice G., Martin RJ, Markus HS. Clinical spectrum of CADASIL and the effect of cardiovascular risk factors on phenotype: study in 200 consecutively recruited individuals. Stroke. 2010; 41 (4): 630-4.

21. Ajimi Y, Uchida K, Kawase T, Toya S. A case of Turner’s syndrome associated with moyamoya disease.

22. Amlie-Lefond C, Bernard TJ, Sdbire G, Friedman NR, Heyer GL, Lerner NB, DeVeber G, Fullerton HJ; International Pediatric Stroke Study Group. Predictors of cerebral arteriopathy in children with arterial ischemic stroke: results of the International Pediatric Stroke Study. Circulation. 2009 Mar 17;119(10):1417-23

23. Aoyagi M, Ogami K, Matsushima Y, Shikata M, Yamamoto M, Yamamoto K. Human leukocyte antigen in patients with moyamoya disease.Stroke. 1995 Mar;26(3):415-7.

24. Aming C. Nonatherosclerotic disease of the cervical arteries: role of ultrasonography for diagnosis. Vasa 2001; 30: 160-167.

25. Aslan H, Gungorduk K, Yildirim G, Ceylan Y. Prenatal diagnosis of arterial tortuosity syndrome. Ultrasound Obstet Gynecol. 2008 Oct;32(5):714-5.

26. Aslan H, Gungorduk K, Yildirim G, Ceylan Y. Prenatal diagnosis of arterial tortuosity syndrome. Ultrasound Obstet Gynecol. 2008 Oct;32(5):714-5.

27. Bajaj A, Li Q, Zheng Q, Pumiglia K. Loss of NFl expression in human endothelial cells promotes autonomous proliferation and altered vascular morphogenesis. PLoS ONE. 2012;7(l 1): e49222.

28. Balfour, G.W.: Clinical Lectures and Disease of the Heart and Aorta. Ed 3, London, Adam and Charles Black, 1898, p. 412.

29. Begelman SM, Olin J.W. Fibromuscular dysplasia. Curr Opin Rheumatol 2000; 12: 1: 41- 47.

30. Berg J., Porteous M., Reinhardt D., et al. Hereditary haemorrhagic telangiectasia: a questionnaire based study to delineate the different phenotypes caused by endoglin and ALKl mutations. J. Med. Genet. 2003 40: 585-590.

31. Beuren, A.J., Hort, W., Kalbfleisch, H., Muller, H., Stoermer, J. Dysplasia of the systemic and pulmonary arterial system with tortuosity and lengthening of the arteries: new entity, diagnosed during life, and leading to coronary death in early childhood. Circulation 39: 109-115, 1969.

32. Bober M.B., Khan N., Kaplan J., et al. Majewski Osteodysplastic primordial dwarfism type II (MOPD II): expanding the vascular phenotype.

33. Braun K.P., Bulder M.M., Chabrier S., Kirkham F.J., Uiterwaal C.S., Tardieu M, Sdbire G. The course and outcome of unilateral intracranial arteriopathy in 79 children with ischaemic stroke. Brain. 2009 Feb; 132(2): 544-557.

34. Brisman R., Abbassioun K. Familial intracranial aneurysms. J. Neurosurg. 1971 May;34(5):678-82.

35. Caims A.G., North K.N. Cerebrovascular dysplasia in neurofibromatosis type 1. J. Neurol Neurosurg Psychiatr. 2008;79(10): 1165-1170.

36. Campman S.C., Holmes J.F., Sokolove P.E., et al. Pulmonary arterial Abromuscular dysplasia: a rare cause of fulminant Iunghemorrhage. Am J Forensic Med Pathol. 2000 Mar. 21(l):69-73.

37. Cano A., Roquer J., Herraiz J. et al. Moyamoya syndrome. Diagnosis with angio-MRI. Arch. Neurobiol. 1992. Vol. 55. № 6. P. 276-279.

38. Cartwright M.S., Hickling W.H., Roach E.S. Ischemic stroke in an adolescent with arterial tortuosity syndrome. Neurology. 2006 Jul 25;67(2):360-l.

39. Castori M., Ritelli M., Zoppi N., et al. Adult presentation of arterial tortuosity syndrome in a 51-year-old woman with a novel homozygous c. 1411+lG>A mutation in the SLC2A10 gene. AmJMedGenetA. 2012May;158 A(5): 1164-9.

40. Cerebrovascular Diseases. Ed. by B.P. Garg, A. Bruno, J. Biller. Philadelphia: Lippencot- Raven Publichers, 1997. P. 489-493.

41. Chabriat H., Joutel A., Dichgans M., Toumier-Lasserve E., Bousser M.G. CADASΓL. LancetNeurology. 2009; 8 (7): 643-53

42. Chan J., D¹Ambrosio Rodriguez F., Sahni D., Boucher-Berry C. Moyamoya Disease with Coexistent Hypertriglyceridemia in Pediatric Patient. Case Rep Endocrinol. 2016; 7974182.

43. Chen H.I., Stiefel M.F., Ernst L., Cahill A.M., Hurst R., Storm P.B. Multiple ruptured cerebral aneurysms in a child with Takayasu arteritis. J Neurosurg Pediatr. 2008 Jan;l(l):83-7.

44. Chiarelli N., Ritelli M., Zoppi N., et al. Characterization and expression pattern analysis of the facilitative glucose transporter 10 gene (slc2alθ) in Danio rerio.

45. Chiche L., Bahnini A., Koskas F., Kieffer E. Occlusive Abromuscular disease of arteries Supplyingthebrain: results of surgical treatment. Ann Vasc Surg. 1997 Sep. ll(5):496-504.

46. Choi JC. Cerebral autosomal dominant arteriopathy with subcortical infarcts and Ieukoencephalopathy: a genetic cause of cerebral small vessel disease. J. Clin. Neurol. 2010; 6: 1-9.

47. Codd P.J., Scott R.M., Smith E.R. Seckel syndrome and moyamoya. J. Neurosurg Pediatr. 2009;3(4):320-324.

48. Collins G.J. Jr, Rich N.M., Clagett GP., et al. Fibromuscular dysplasia of the internal carotid arteries. Clinical experience and follow-up. Ann Surg. 1981 Jul. 194(l):89-96.

49. Collongues N., Derache N., Blanc F. Inflammatory-Iike presentation of CADASIL: a diagnostic challenge. BMCNeurol. 2012; 12:78. doi: 10.1186/1471-2377-12-78.

50. Connor S.E., Hewes D., Ball C., Jarosz J.M. Alagille syndrome associated with angiographic moyamoya. ChildsNerv Syst. 2002; 18(3-4): 186-190.

51. Coulson W.T.: Peculiar disposition of large vessels producing tumor at root neck. Trans Path Soc London 3: 302, 1852.

52. Davous P. CADASIL: a review with proposed diagnostic criteria Eur. J. Neurol. 1998. Vol. 5, №3. P. 219-233.

53. Dobson S.R., Holden K.R., Nietert P.J., et al. Moyamoya syndrome in childhood sickle cell disease: a predictive factor for recurrent cerebrovascular events. Blood. 2002;99(9):3144-3150.

54. Dotti M.T., Federico A., Mazzei R., et al. The spectrum of Notch3 mutations in 28 Italian CADASIL families. J. Neurol. Neurosurg. Psychiatry. 2005; 76: 736-8.

55. Drera B., Barlati S., Colombi M. Ischemic stroke in an adolescent with arterial tortuosity syndrome. Neurology. 2007 May 8;68(19):1637; author reply 1637.

56. Drera B., Barlati S., Colombi M. Ischemic stroke in an adolescent with arterial tortuosity syndrome. Neurology. 2007 May 8;68(19):1637; author reply 1637.

57. Emerick K.M., Krantz I.D., Kamath B., et al. Intracranial vascular abnormalities in patients with Alagille syndrome.

58. Eppinger H. Stenosis aortae congenita seu isthmus persistens. Vrtljschr Prakt Heilk 112:31-67, 1871.

59. Ertugrel A. Diffuse tortuosity and lengthening of the arteries. Circulation 36: 400-407, 1967.

60. Faiyaz-Ul-Haque M., Zaidi S.H., Al-Sanna N., et al. A novel missense and a recurrent mutation in SLC2A10 gene of patients affected with arterial tortuosity syndrome. Atherosclerosis. 2009. Apr;203(2):466-71.

61. Fujima N., Osanai T., Shimizu Y., Yoshida A., Harada T., Nakayama N., et al. Utility of noncontrast-enhanced time-resolved four-dimensional MR angiography with a vessel- selective technique for intracranial arteriovenous malformations. J Magn Reson Imaging. 2016. Mar 10.

62. Fung L.W., Thompson D., Ganesan V. Revascularisation surgery for paediatric moyamoya: a review of the literature. Childs Nerv Syst. 2005 May. 21(5):358-64.

63. Fung L.W., Thompson D., Ganesan V. Revascularisation surgery for paediatric moyamoya: a review of the literature. Childs Nerv Syst. 2005 May. 21(5):358-64.

64. Gaba R.C., Shah R.P., Muskovitz A.A., Guzman G., Michals E.A. Synchronous moyamoya syndrome and ruptured cerebral aneurysm in Alagille syndrome. J Clin Neurosci. 2008; 15(12): 1395—1398.

65. Ganesan V., Kirkham F.J. Noonan syndrome and moyamoya. Pediatr Neurol.

1997; 16(3):256—258.

66. Ghosh P.S., Rothner A.D., Emch TM., Friedman N.R., Moodley M. Cerebral vasculopathy in children with neurofibromatosis type 1. J Child Neurol. 2013;28(l):95— 101.

67. Gray G.H., Young J.R., Olin J.W. Miscellaneous arterial diseases. Young J.R., Olin J.W., Bartholomew J., eds. Peripheral Vascular Diseases. 2nd ed. St Louis: Mosby-Yearbook; 1996. 425-40.

68. Guo D.C., Papke C.L., Tran-Fadulu V., et al. Mutations in smooth muscle alpha-actin (ACTA2) cause coronary artery disease, stroke, and Moyamoya disease, along with thoracic aortic disease. Am J Hum Genet. 2009;84(5):617-627.

69. Guttmacher A.E, Marchuk D.A., White R.I.Jr. Hereditary hemorrhagic telangiectasia. New Eng. J. Med. 1995 333: 918-924.

70. Hamilton S.J., Friedman J.M. Insights into the pathogenesis of neurofibromatosis 1 vasculopathy. ClinGenet. 2000;58(5):341-344.

71. Harrison E.G. Jr, McCormack L.J. Pathologic classification of renal arterial disease in renovascular hypertension. Mayo Clin Proc. 1971 Mar. 46(3): 161-7.

72. Hetts S.W., Narvid J., Sanai N., Lawton M. T., Gupta N., Fullerton H. J., Dowd C.F., Higashida R.T., Halbach V.V. Intracranial aneurysms in childhood: 27-year single­institution experience Am JNeuroradiol. 2009. vol. 30. P. 1315-1324.

73. Heyer GL., Dowling M.M., Licht D.J., et al. The cerebral vasculopathy of PHACES syndrome. Stroke. 2008;39(2):308-316.

74. Hiratzka L.F., Creager M.A., Isselbacher E.M., Svensson L.G. 2010 ACCF∕AHA∕AATS∕ACR∕ASA∕SCA∕SCAI∕SIR∕STS∕SVM Guidelines for the Diagnosis and Management of Patients with Thoracic Aortic Disease Representative Members., Hiratzka L.F., Creager M.A., Isselbacher E.M., Svensson L.G.; 2014 AHA/ACC Guideline for the Management of Patients with Valvular Heart Disease Representative Members., Nishimura R.A., Bonow R.O., Guyton R.A., Sundt TM. 3rd. J Thorac Cardiovasc Surg. 2016 Apr;151(4):959-66. doi: 10.1016/j.jtcvs.2015.12.001.

75. Jagannath A.D., Rastogi U., Spooner A.E., Lin A.E., Agnihotri A.K. Aortic dissection and moyamoya disease in Turner syndrome. Am J Med Genet A. 2010;152A (8) :2085-2089.

76. Jahnlova D, Veselka J. Fibromuscular Dysplasia of Renal and Carotid Arteries. Int J Angiok 2015 Sep; 24(3): 241-243. Published online 2015 Apr 24. doi: 10.1055∕s-0034- 1396931

77. James T.N. Morphologic characteristics and functional significance of focal Fibromuscular dysplasia of small coronary arteries. Am J Cardiol. 1990 Apr 3. 65(14): 12G-22G.

78. Jea A., Smith E.R., Robertson R., Scott R.M. Moyamoya syndrome associated with Down syndrome: outcome after surgical revascularization. Pediatrics. 2005;116(5): e694-e701.

79. Jennifer K.W. Chesnutt, Hai-Chao Han Tortuosity Triggers Platelet Activation and ThrombusFormationinMicrovessels. JBiomechEng. 2011 December; 133(12): 121004.

80. Joutel A., Vahedi K., Corpechot C., et al. Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients. Lancet. 1997; 350: 1511-5.

81. Kadian-Dodov D., Gomik H.L., Xiaokui Gu., et al, Dissection and Aneurysm in Patients with Fibromuscular Dysplasia. Findings from the U.S. Registry for FMD. J Am Coll Cardiol. 2016;68(2):176-185.

82. Kainth D.S., Chaudhry S.A., Kainth H.S., Suri F.K., Qureshi A.I. Prevalence and characteristics of concurrent down syndrome in patients with moyamoya disease. Neurosurgery. 2013;72(2):210-215.

83. Kalimo H., Ruchoux M., Viitanen M., et al. CADASΓL: a common form Ofhereditary arteriopathy causing brain infarcts and dementia Brain Pathol. 2002. Vol. 12. P. 371-384.

84. Kamada F., Aoki Y., Narisawa A., Abe Y., Komatsuzaki S., Kikuchi A., et al. A genome­wide association study identifies RNF213 as the first Moyamoya disease gene. J Hum Genet. 2011 Jan. 56(l):34-40.

85. Kamath B.M., Spinner N.B., Emerick K.M., et al. Vascular anomalies in Alagille syndrome: a significant cause of morbidity and mortality. Circulation. 2004; 109(11): 1354- 1358.

86. Kim D.H., Van Ginhoven G., Milewicz D.M. Incidence of familial intracranial aneurysms in 200 patients: comparison among Caucasian, African-American, and Hispanic populations. Neurosurgery. 2003 Aug;53(2):302-8.

87. Kim H, Abla A.A., Nelson J., McCulloch C.E., Bervini D., Morgan M.K., et al. Validation of the supplemented Spetzler-Martin grading system for brain arteriovenous malformations in a multicenter cohort of 1009 surgical patients. Neurosurgery. 2015 Jan. 76 (1):25-31; discussion 31-2; quiz 32-3.

88. Kim H., Pourmohamad T., Westbroek E.M., McCulloch C.E., Lawton M.T., Young W.L. Evaluating performance of the spetzler-martin supplemented model in selecting patients with brain arteriovenous malformation for surgery. Stroke. 2012 Sep. 43 (9):2497-9.

89. Lawton M.T., Kim H., McCulloch C.E., Mikhak B., Young WL. A supplementary grading scale for selecting patients with brain arteriovenous malformations for surgery. Neurosurgery. 2010 Apr. 66 (4):702-13; discussion 713.

90. Kim J.-K., Kim Y.-J. GDC Embolization OfIntracranial Aneurysms with SAH and Mass Effect by Subdural A Case Report and Review. Interv Neuroradiol. 2004 March; 10(1): 47-51.

91. Kim J.S. Moyamoya Disease: Epidemiology, Clinical Features, and Diagnosis. J Stroke. 2016 Jan. 18 (1):2-11.

92. Kim S.J., Heo K.G., Shin HY., Bang O.Y., Kim GM., Chung C S. Association of thyroid autoantibodies with moyamoya-type cerebrovascular disease: a prospective study. Stroke. 2010 Jan. 41(l):173-6.

93. Kincaid 0.W., Davis G.D., Hallermann F.J., Hunt J.C. Fibromuscular dysplasia of the renal arteries: arteriOgraphic features, classification, and observation on natural history of the disease. Am JRoentgenol. 1968;104:271-282.

94. Kiyoshi Uike, Yuki Matsushita, Yasunari Sakai, Osamu Togao, Michinobu Nagao, Yoshito Ishizaki, 1 Hazumu Nagata, Kenichiro Yamamura, Hiroyuki Torisu, Toshiro Hara Systemic vascular phenotypes of Loeys-Dietz syndrome in a child carrying a de novo R381P mutation in TGFBR2: a case report BMC Res Notes. 2013; 6: 456.

95. Kodama N., Aoki Y., Hiraga H., Wada T., Suzuki J. Electroencephalographic findings in children with moyamoya disease. Arch Neurol. 1979 Jan;36(l):16-9.

96. Kudo T. (1968) Spontaneous occlusion of the circle of Willis. A disease apparently confined to Japanese. Neurology 18:485-496.

97. Lasjaunias P., Wuppalapati S., Alvarez S. Intracranial aneurysms in children aged under 15 years: review of 59 consecutive children with 75 aneurysms Childs. Nerv. Syst. 2005. Vol. 21.P. 437-450

98. Lees M.H., Menash E.V., Sunderland C.0., Magan C.L., Dawson P.J. Ehlers-Danlos syndrome associated with multiple pulmonary artery stenoses and tortuous systemic arteries. JPediatr. 1969; 75:1031-6.

99. Li Y., Shi Z., Cai Y., et al. Impact of coronary tortuosity on coronary pressure: numerical simulation study. PLoS One. 2012;7(8): e42558.

100. Liang J.J., Tweet M.S., Hayes S.E., Gulati R., Hayes S.N. Prevalence and predictors of depression and anxiety among survivors of myocardial infarction due to spontaneous coronary artery dissection. J Cardiopulm Rehabil Prev 2014; 34:138-42.

101. Liebeskind D.S., et al, 2016 http://emedicine.medscape.com.

102. Loeys B.L., Schwarze U., Holm T., et al. Aneurysm syndromes caused by mutations in the TGF-beta receptor. New England Journal of Medicine.2006. No355. P. 788-798.

103. Luscher T.F., Lie J.T., Stanson A.W., et al. Arterial Fibromuscular dysplasia. Mayo Clin Proc. 1987 Oct. 62(10):931-52.

104. Ma J., Liu Y., Ma L., Huang S., Li H., You C. RNF213 polymorphism and Moyamoya disease: A systematic review and meta-analysis. Neurol India. 2013 Jan-Feb. 61(l):35-9. [Medline],

105. Major P., Genest J., Cartier P., Kuchel O. Hereditary fibromuscular dysplasia with renovascular hypertension. Ann Intern Med. 1977 May;86(5):583.

106. Manjila S., Miller B.R., Rao-Frisch A., et al. Moyamoya Disease Associated with Asymptomatic Mosaic Turner Syndrome: A Rare Cause of Hemorrhagic Stroke. J Stroke Cerebrovasc Dis. 2014;23(5): 1242-1244.

107. Marco Zenteno, Angel Lee, Hemando Raphael Alvis-Miranda, Luis Rafael Moscote-Salazar Cerebral aneurysm in a patient with Loeys-Dietz syndrome J Neurosci RuralPract. 2014 Apr-Jun; 5(2): 198-199. doi: 10.4103/0976-3147.131687.

108. Maresi E., Becchina G., Ottoveggio G., et al. Arrhythmic sudden cardiac death in a 3-year-old child with intimal fibroplasia of coronary arteries, aorta, and its branches. CardiovascPathol. 2001 Jan-Feb. 10(l):43-8.

109. Markus H.S. Genes for stroke. J. Neurol. Neurosurg. Psychiatry. 2004. Vol. 75. P. 1229-1231.

110. Matson D.D. Intracranial arterial aneurysms in childhood. J Neurosurg 23:578-583, 1965

111. Matsushima Y., Aoyagi M., Niimi Y., Masaoka H., Ohno K. Symptoms and their pattern of progression in childhood moyamoya disease. Brain Dev. 1990;12(6):784-9.

112. McCormack L.J., Poutasse E.F., Meaney T.F., Noto T.J., Jr, Dustan H.P. A pathologic-arteriographic correlation of renal arterial disease. Am Heart J. 1966;72:188— 198. doi: 10.1016∕0002-8703(66)90442-X.

113. McCormick WF. The pathology of vascular ("arteriovenous") malformations. J Neurosurg. 1966 Apr. 24(4):807-16.

114. McDonald C., Korb M.: Intracranial aneurysms. Arch Neurol Psychiatry 42:298- 328, 1939.

115. Mettinger K.L., Ericson K. Fibromuscular dysplasia and the brain. I. Observations on angiographic, clinical and genetic characteristics. Stroke 13: 46-52, 1982.

116. Mineham Y., Liu W., Inoue K., Matsuura N., Inoue S., Takenaka K. Autosomal dominant moyamoya disease maps to chromosome 17q25.3. Neurology. 2008 Jun 10. 70(24 Pt 2):2357-63.

117. Mineham Y., Takenaka K., Yamakawa H., et al. Inheritance pattern of familial moyamoya disease: autosomal dominant mode and genomic imprinting. J Neurol Neurosurg Psychiatry. 2006 Sep. 77(9): 1025-9.

118. Moceri P., Albuisson J., Saint-Faust M., et al. Arterial tortuosity syndrome: early diagnosis and association with venous tortuosity. J Am Coll Cardiol. 2013 Feb 19;61(7):783.

119. Moftakhar P., Smith E.R., Choulakian A., Scott R.M., Danielpour M. Moyamoya disease in children with congenital dwarfing conditions. Pediatr Neurosurg. 2010;46(5):373-380.

120. Moritani T, Numaguchi Y, Lemer NB, et al. Sickle cell cerebrovascular disease: usual and unusual findings on MR imaging and MR angiography. Clin Imaging. 2004;28(3): 173-186.

121. Moriyasu N (1964) Angiographic and clinical features of cases with cerebrovascular abnormality demonstrating apoplectic symptoms. Nihon Iji Shinpo 2085:16-22.

122. Nahed B.V., Bydon M., Ozturk A.K. et al. Genetics of intracranial aneurysms. Neurosurgery. - 2007. - Vol. 60 (2). -P. 213-225.

123. National Institutes of Health Consensus Development Conference Statement: neurofibromatosis. Neurofibromatosis. 1988; 1(3): 172-178.

124. Naunheim MR, Walcott BP, Nahed BV, et al. Arterial tortuosity syndrome with multiple intracranial aneurysms: a case report. Arch Neurol. 2011 Mar;68(3):369-71.

125. Nishimoto A, Takeuchi S (1968) Abnormal cerebrovascular network related to the internal carotid arteries. JNeurosurg 29:255-260.

126. Olin JW, Sealove BA. Diagnosis, management, and future developments of Abromuscular dysplasia. J Vasc Surg 2011; 53:826-36.

127. Osenbach R. K. Giant aneurysm of the distal posterior inferior cerebellar artei у in an 11-month-old child presenting with obstructive hydrocephalus. Pediatr Neurosci. — 1989. —vol. 15. -P. 30-312

128. Ostergaard J.R., Voldby B. Intracranial arterial aneurysms in children and adolescents. J.Neurosurg. - 1983. - Vol. 58. - P. 832-837

129. Packinson, J., Bedford, D. E., и Almond, S.: Kinked carotid artery that simulates aneurysm. Brit Heart J 1: 345, 1939.

130. Park YS, Min KT, Kim TG, et al. Age-specific eNOS polymorphisms in moyamoya disease. ChildsNerv Sysf 2011;27(11): 1919-1926.

131. Perry LD, Robertson F, Ganesan V. Screening for cerebrovascular disease in microcephalic Osteodysplastic primordial dwarfism type ∏ (MOPD II): an evidence-based proposal. PediatrNeurol. 2013;48(4):294-298.

132. Pescini F, Nannucci S, Bertaccini B, Salvadori E, Bianchi S, Ragno M, et al. Cerebral Autosomal-Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL) Scale: a screening tool to select patients for N0TCH3 gene analysis. Stroke. 2012; 43(11): 2871-6.

133. Pierre-Frangois Plouin, Jdrome Perdu, Agnes La Batide-Alanore, Pierre Boutouyrie, Anne-Paule Gimenez-Roqueplo, Xavier Jeunemaitre Fibromuscular dysplasia. Orphanet J Rare Dis. 2007; 2: 28. Published online 2007 Jun 7. doi: 10.1186/1750-1172-2-28.

134. Plasencia AR, Santillan A. Embolization and radiosurgery for arteriovenous malformation. Surg Neurol Int. 2012; 3(Suppl 2): S90-S104. Published online 2012 Apr 26.

135. Porras JL, Yang W, Garzon-Muvdi T, Xu R, Blakeley J, Belzberg A, Caplan JM, Khalid S, Colby GP, Coon AL, Tamargo RJ, Ahn ES, Huang J. Surgical Treatment for Patients with Moyamoya Syndrome and Type 1 Neurofibromatosis. World Neurosurg. 2016 Nov 19. pii: S1878-8750(16)31199-8. doi: 10.1016∕j.wneu.2016.11.051. [Epub ahead of print],

136. Rachmel A, Zeharia A, Neuman-Levin M, Weitz R, Shamir R, Dinari G. Alagille syndrome associated with moyamoya disease. Am J Med Genet. 1989;33( 1):89—91

137. Ramesh V, Bernardi B, Stafa A, et al. Intracerebral large artery disease in Aicardi- Goutieres syndrome implicates SAMHDl in vascular homeostasis. Dev Med Child Neurol. 2010;52(8):725-732.

138. Rana A. K., Koumellis P., Jaspan T., Cartmill M., McConachie N. S. Coil embolization of ruptured middle cerebial artery aneurysms in the first 2 months of life. Report of two cases. J Neurosuigery (3 Suppl Pediatrics). 2007. - vol. 107. - P. 232-235

139. Rea D, Brandsema JF, Armstrong D, et al. Cerebral arteriopathy in children with neurofibromatosis type 1. Pediatrics. 2009;124(3): e476-e483.

140. Ren SC, Gao BQ, Yang WL, Feng WX, Xu J, Li SW, Wang YJ.Von Willebrand factor and coagulation factor VIII in Moyamoya disease associated with Graves' disease: A case report. Exp Ther Med. 2016 Nov;12(5):3195-3200.

141. Rocha R, Soro I, Leitao A, Silva ML, Leao M. Moyamoya vascular pattern in Alagille syndrome. PediatrNeurol. 2012;47(2): 125-128.

142. Rosser TL, Vezina G, Packer RJ. Cerebrovascular abnormalities in a population of children with neurofibromatosis type 1. Neurology. 2005;64(3):553-555.

143. Roy U, Das U, Panwar A, Lal PK. Dystonia, myoclonus, and encephalopathy in a single patient: A rare association of moyamoya. Ann Afir Med. 2016 Oct-Dec; 15(4):200- 203. doi: 10.4103/1596-3519.194284.

144. Rushton AR. The genetics of Abromuscular dysplasia. Arch Intern Med. 1980 Feb;140(2):233-6.

145. Sakai N, Sakata K, Yamada H, Yamamoto M, Aiba T, Takeda F. Familial Occurrenceofintracranial aneurysms. SurgNeurol. 1974 Jan;2(l):25-9.

146. Schuster JM, Roberts TS. Symptomatic moyamoya disease and aortic coarctation in a patient with Noonan’s syndrome: strategies for management. Pediatr Neurosurg. 1999;30(4):206-210.

147. Scott RM, Smith JL, Robertson RL, et al. Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis. J Neurosurg. 2004 Feb. 100(2 Suppl Pediatrics): 142-9.

148. Shiari R, Tabatabaei Nodushan SM, Mohebbi MM, Karimzadeh P, Javadzadeh M. Moyamoya Syndrome Associated with Henoch-Schonlein Purpura. Iran J Child Neurol. 2016 Fall;10(4):71-74.

149. Shiihara T, Kato M, Mitsuhashi Y, Hayasaka K. Costello syndrome showing moyamoya-like vasculopathy. PediatrNeurok 2005;32(5):361-363.

150. Shimidzu K (1937) Beitraege zur Arteriographie des Gehims-einfache percutane Methode. Arch klin Chir 188:295-316.

151. Siegel DH, Tefft KA, Kelly T, et al. Stroke in children with posterior fossa brain malformations, hemangiomas, arterial anomalies, coarctation of the aorta and cardiac defects, and eye abnormalities (PHACE) syndrome: a systematic review of the literature. Stroke. 2012;43(6): 1672-1674.

152. Silberstein SD, Lipton RB, Dalessio Wolffs DJ. Headache and Other Head Pain. Oxford: University Press, 2001. —P. 378-379.

153. Singhal S, Bevan S, Barrick T, Rich P, Markus HS. The influence of genetic and cardiovascular risk factors on the CADASIL phenotype. Brain. 2004; 127 (9): 2031-8.

154. Slovut DP, Olin JF. Fibromuscular dysplasia. N Engl J Med 2004; 350: 1862— 1871.

155. Speck V, Noble A, Kollmar R, Schenk T. Diagnosis of spontaneous cervical artery dissection may be associated with increased prevalence of posttraumatic stress disorder. J Stroke Cerebrovasc Dis 2014; 23:335-42.

156. Spengos K, Kosmaidou-Aravidou Z, Tsivgoulis G, Vassilopoulou S, Grigori- Kostaraki P, Zis V. Moyamoya syndrome in a Caucasian woman with Turner’s syndrome. EurJNeurok 2006; 13(10): e7-e8.

157. Srinivasaraghavan R, Krishnamurthy S, Mahadevan S. Catastrophic intracranial hemorrhage as a presenting feature of juvenile polyarteritis nodosa. J Child Neurol. 2014 Jun;29(6):826-9.

158. Stanley JC, Gewertz BL, Bove EL, et ah Arterial fιbrodysplasia. Histopathologic character and current etiologic concepts. Arch Surg. 1975 May. 110(5):561-6.

159. Starke RM, Komotar RJ, Hickman ZL, et al. Clinical features, surgical treatment, and long-term outcome in adult patients with moyamoya disease. Clinical article. J Neurosurg. 2009 Nov. 111(5):936-42.

160. Strassman: Der plotzliche Tod bei Stenose des Isthmus Aortae. Beitr gerichtl Med 5:91-97, 1922

161. Suzuki J, KodamaN. Moyamoya disease—a review. Stroke. 1983 14:104-109. doi: 10.1161/01.STR.14.1.104.

162. Suzuki J, Takaku A (1969) Cerebrovascular “moyamoya” disease. Disease showing net-like vessels in base of brain. Arch Neurol 20:288-299.

163. Suzuki, J. (ed.). Moyamoya Disease. Berlin; New York: Springer-Verlag 1986.

164. Switzer JA, Hess DC, Nichols FT, Adams RJ. Pathophysiology and treatment of stroke in sickle-cell disease: present and future. LancetNeurol. 2006;5(6):501-512.

165. Takeuchi K, Shimizu K (1957) Hypoplasia of the bilateral internal carotid arteries. No To Shinkei 9:37-43.

166. Tang KT, Yang W, Wong J, Lee KY. Noonan syndrome associated with moyamoya disease: report of one case. Acta Paediatr Taiwan. 1999;40(4):274-276.

167. ter Berg JW, Ludwig JW, Bijlsma JB, Tulleken CA, Willemse J. Clinical-genetic aspects, early diagnosis and neurosurgical treatment of familial intracranial aneurysms], Ned Tijdschr Geneeskd. 1987 Apr 18;131(16):670-5.

168. Tikka S, Mykkanen K, Ruchoux MM, et al. Congruence between NOTCH3 mutations and GOM in 131 CADASIL patients. Brain. 2009; 132: 933 - 9.

169. Toglia JU, Samii AR. Familial intracranial aneurysms. Dis Nerv Syst. 1972 Sep;33(9):611-3.

170. Toyoda K, Tsutsumi K, Hirao T, Ono T, Takahata H, Toda K, Baba H, Ito M, Yonekura M. Ruptured intracranial aneurysms in pediatric polyarteritis nodosa: case report. Neurol Med Chir (Tokyo). 2012;52(12):928-32

171. Turnpenny PD, Ellard S. Alagille syndrome: pathogenesis, diagnosis and management. Eur J Hum Genet. 2012;20(3):251-257.

172. Uchino K, Johnson A, Claiborne S, Tirschwell DL. Moyamoya disease in Washington State and California. Neurology. 2005. 65:956-958.

173. Van Damme H, Sakalihasan N., Limet R. Fibromuscular dysplasia of the internal carotid artery: personal experience with 13 cases and literature review. Acta Chir Belg 1999; 99: 163—168.

174. Venkatraman Bhat. Arterial Tortuosity Syndrome: An Approach through Imaging Perspective. J Clin Imaging Sci. 2014; 4: 44. Published online 2014 Aug 30. doi: 10.4103/2156-7514.139734

175. Vyshka G, Kruja J. Clinical variability of the cerebral autosomal-dominant arteriopathy with subcortical infarcts and Ieukoencefalopathy phenotype in two siblings of a large family showing the same mutation. Int. Med.Case. Rep. J. 2013; 6:59-63.

176. Wakai K, Tamakoshi A, Ikezaki K, Fukui M, Kawamura T, Aoki R, Kojima M, Lin Y, Ohno Y. Epidemiological features of moyamoya disease in Japan: findings from a nationwide survey. Clin Neurol Neurosurg. 1997 Oct;99 Suppl 2: S1-5.

177. Wang X, Zhang Z, Liu W, et al. Impacts and interactions of PDG-FRB, MMP-3, TΓMP-2, and RNF213 polymorphisms on the risk of Moyamoya disease in Han Chinese human subjects. Gene. 2013;526(2):437-442.

178. Wessels MW, Catsman-Berrevoets CE, Mancini GM, et al. Three new families with arterial tortuosity syndrome. Am J Med Genet A. 2004 Dec 1; 131(2): 134-43.

179. Williams JA, Loeys BL, Nwakanma LU, Dietz HC, Spevak PJ, Patel ND, et al. Early surgical experience with Loeys-Dietz: A new syndrome of aggressive thoracic aortic aneurysm disease. Ann Thorac Surg 2007; 83 : S 757-63.

180. Woolfenden AR, Albers GW, Steinberg GK, Hahn JS, Johnston DC, Farrell K. Moyamoya syndrome in children with Alagille syndrome: additional evidence of a vasculopathy. Pediatrics. 1999; 103(2):505—508.

181. Xin B, Jones S, Puffenberger EG, et al. Homozygous mutation in SAMHDl gene causes cerebral vasculopathy and early onset stroke. Proc Natl Acad Sci USA. 2011; 108(13):5372—5377.

182. Yamashita Y, Kusaga A, Koga Y, Nagamitsu S, Matsuishi T. Noonan syndrome, moyamoya-like vascular changes, and antiphospholipid syndrome. Pediatr Neurol. 2004;31(5):364-366.

183. Yeon JY, Shin HJ, Seol HJ, Kim JS, Hong SC. Unilateral intracranial arteriopathy in pediatric stroke: course, outcome, and prediction of reversible arteriopathy. Stroke. 2014 Apr;45(4): 1173-6

В работе использованы материалы следующих сайтов:

http://emedicine.medscape.

http://emedicine.medscape.com.

http://online-diagnos.ru/illness/d/bolezn-moya-moya

http://psytheater.com

http://sosudo.ru

http://www.medicus.ru/hsurgery/specialist/bolezn-i-sindrom-mojya-mojya-23851.phtml

http://www.polismed.com.

http://www.practiceupdate.com